These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23720012)

  • 1. DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome.
    ; Savige J; Ars E; Cotton RG; Crockett D; Dagher H; Deltas C; Ding J; Flinter F; Pont-Kingdon G; Smaoui N; Torra R; Storey H
    Pediatr Nephrol; 2014 Jun; 29(6):971-7. PubMed ID: 23720012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
    Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
    PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Alport syndrome COL4A5 variant database.
    Crockett DK; Pont-Kingdon G; Gedge F; Sumner K; Seamons R; Lyon E
    Hum Mutat; 2010 Aug; 31(8):E1652-7. PubMed ID: 20574986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome.
    Gibson JT; Huang M; Shenelli Croos Dabrera M; Shukla K; Rothe H; Hilbert P; Deltas C; Storey H; Lipska-Ziętkiewicz BS; Chan MMY; Sadeghi-Alavijeh O; Gale DP; ; Cerkauskaite A; Savige J
    Sci Rep; 2022 Feb; 12(1):2722. PubMed ID: 35177655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-Linked Glomerulopathy Due to COL4A5 Founder Variant.
    Barua M; John R; Stella L; Li W; Roslin NM; Sharif B; Hack S; Lajoie-Starkell G; Schwaderer AL; Becknell B; Wuttke M; Köttgen A; Cattran D; Paterson AD; Pei Y
    Am J Kidney Dis; 2018 Mar; 71(3):441-445. PubMed ID: 29198386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenicity of missense variants affecting the collagen IV α5 carboxy non-collagenous domain in X-linked Alport syndrome.
    Gibson JT; Sadeghi-Alavijeh O; Gale DP; Rothe H; ; Savige J
    Sci Rep; 2022 Jul; 12(1):11257. PubMed ID: 35789182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessing the pathogenicity of c.2858G>T(p.(G953V)) in COL4A5 Gene: report of 19 Chinese families.
    Zhang Y; Ding J; Wang S; Zhang H; Zhong X; Liu X; Xu K; Wang F
    Eur J Hum Genet; 2020 Feb; 28(2):244-252. PubMed ID: 31576025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay.
    Horinouchi T; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Ishimori S; Kaito H; Matsuo M; Iijima K; Nozu K
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1342. PubMed ID: 32543079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts.
    Wang F; Wang Y; Ding J; Yang J
    Kidney Int; 2005 Apr; 67(4):1268-74. PubMed ID: 15780079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome.
    Helle OMB; Pedersen TH; Ousager LB; Thomassen M; Hertz JM
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1452. PubMed ID: 32812400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert consensus guidelines for the genetic diagnosis of Alport syndrome.
    Savige J; Ariani F; Mari F; Bruttini M; Renieri A; Gross O; Deltas C; Flinter F; Ding J; Gale DP; Nagel M; Yau M; Shagam L; Torra R; Ars E; Hoefele J; Garosi G; Storey H
    Pediatr Nephrol; 2019 Jul; 34(7):1175-1189. PubMed ID: 29987460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central/East Europe and causes kidney failure in midlife.
    Żurowska AM; Bielska O; Daca-Roszak P; Jankowski M; Szczepańska M; Roszkowska-Bjanid D; Kuźma-Mroczkowska E; Pańczyk-Tomaszewska M; Moczulska A; Drożdż D; Hadjipanagi D; Deltas C; Ostalska-Nowicka D; Rabiega A; Taraszkiewicz J; Taranta-Janusz K; Wieczorkiewicz-Plaza A; Jobs K; Mews J; Musiał K; Jakubowska A; Nosek H; Jander AE; Koutsofti C; Stanisławska-Sachadyn A; Kuleszo D; Ziętkiewicz E; Lipska-Ziętkiewicz BS
    Kidney Int; 2021 Jun; 99(6):1451-1458. PubMed ID: 33309955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia.
    Arrondel C; Deschênes G; Le Meur Y; Viau A; Cordonnier C; Fournier A; Amadeo S; Gubler MC; Antignac C; Heidet L
    Kidney Int; 2004 Jun; 65(6):2030-40. PubMed ID: 15149316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
    Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
    Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
    Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
    CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female X-linked Alport syndrome with somatic mosaicism.
    Yokota K; Nozu K; Minamikawa S; Yamamura T; Nakanishi K; Kaneda H; Hamada R; Nozu Y; Shono A; Ninchoji T; Morisada N; Ishimori S; Fujimura J; Horinouchi T; Kaito H; Nakanishi K; Morioka I; Taniguchi-Ikeda M; Iijima K
    Clin Exp Nephrol; 2017 Oct; 21(5):877-883. PubMed ID: 27796712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved genetic counseling in Alport syndrome by new variants of COL4A5 gene.
    Fernandez-Rosado F; Campos A; Alvarez-Cubero MJ; Ruiz A; Entrala-Bernal C
    Nephrology (Carlton); 2015 Jul; 20(7):502-5. PubMed ID: 26063487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.